FDA OKs New Drug Saphris for Schizophrenia, Bipolar I Disorder
FDA OKs New Schizophrenia, Bipolar Drug Saphris Trumps Placebo at Reducing Symptoms of Schizophrenia, Bipolar Disorder WebMD Medical News By Miranda Hitti Reviewed by Louise Chang, MD More from WebMD...
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.